Relaxor‐based ferroelectric single crystals, such as (1 − x)Pb(Mg1/3Nb2/3)O3xPbTiO3 (PMNxPT, or PMNT) single crystals, exhibit large pyroelectric response, low thermal diffusivity, and high temperature stability. To fabricate high performance infrared detectors with relaxor‐based single crystals, the related readout circuit was investigated to increase signal‐to‐noise ratio, and 8 × 1 CMOS readout circuit is fabricated to gain very weak current, which provides a solution for uncooled large focal plane arrays devices based on relaxor‐based single crystals.
Abstract:The use of hematite as the photoanode for photoelectrochemical hydrogen production by solar energy has been actively studied due to its abundance, stability, and adequate optical properties. Deposition of an electrocatalyst overlayer on the hematite may increase kinetics and lower the onset potential for water splitting. Ni x Fe 1−x O y is one of the most effective electrocatalysts reported for this purpose. However, the condition and results of the previous reports vary significantly, and a comprehensive model for Ni x Fe 1−x O y /hematite is lacking. Here, we report a simple and novel chemical bath deposition method for depositing low-onset-potential Ni x Fe 1−x O y electrocatalyst on hematite. With a Ni percentage of 80% and an immersion time of 2 min, the as-prepared Ni x Fe 1−x O y overlayer raised the photovoltage from 0.2 V to 0.7 V, leading to a cathodic shift of the onset potential by 400 mV, while maintaining the same level of current density. The dependence of the electrochemical and photoelectrochemical characteristics of the photoanode on the condition of the electrocatalyst was studied systematically and explained based on energy level diagrams and kinetics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.